These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33113009)

  • 1. Transanal total mesorectal excision: 3-year oncological outcomes.
    Ourô S; Albergaria D; Ferreira MP; Costeira B; Roquete P; Ferreira D; Maio R
    Tech Coloproctol; 2021 Feb; 25(2):205-213. PubMed ID: 33113009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncological safety of transanal total mesorectal excision (TaTME) for rectal cancer: mid-term results of a prospective multicentre study.
    Simo V; Tejedor P; Jimenez LM; Hernan C; Zorilla J; Arrredondo J; Lapuente F; Pastor C
    Surg Endosc; 2021 Apr; 35(4):1808-1819. PubMed ID: 32333158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer.
    Deijen CL; Velthuis S; Tsai A; Mavroveli S; de Lange-de Klerk ES; Sietses C; Tuynman JB; Lacy AM; Hanna GB; Bonjer HJ
    Surg Endosc; 2016 Aug; 30(8):3210-5. PubMed ID: 26537907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transanal total mesorectal excision (TaTME) versus laparoscopic TME for MRI-defined low rectal cancer: a propensity score-matched analysis of oncological outcomes.
    Roodbeen SX; Penna M; Mackenzie H; Kusters M; Slater A; Jones OM; Lindsey I; Guy RJ; Cunningham C; Hompes R
    Surg Endosc; 2019 Aug; 33(8):2459-2467. PubMed ID: 30350103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transanal total mesorectal excision (taTME) for rectal cancer: beyond the learning curve.
    D'Andrea AP; McLemore EC; Bonaccorso A; Cuevas JM; Basam M; Tsay AT; Bhasin D; Attaluri V; Sylla P
    Surg Endosc; 2020 Sep; 34(9):4101-4109. PubMed ID: 31602515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transanal mesorectal excision: early outcomes in Australia and New Zealand.
    Lau S; Kong J; Bell S; Heriot A; Stevenson A; Moloney J; Hayes J; Merrie A; Eglinton T; Guest G; Clark D; Warrier S
    Br J Surg; 2021 Mar; 108(2):214-219. PubMed ID: 33711138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short Term Postoperative and Oncological Outcomes of Two-Dimensional Versus Three-Dimensional Laparoscopic Transanal Total Mesorectal Excision of Rectal Cancer.
    Tey HTV; Foo SMJ; Fong SS; Chong CS
    J Laparoendosc Adv Surg Tech A; 2020 Dec; 30(12):1350-1353. PubMed ID: 32522084
    [No Abstract]   [Full Text] [Related]  

  • 8. Transanal (TaTME) vs. laparoscopic total mesorectal excision for mid and low rectal cancer: a propensity score-matched analysis of early and long-term outcomes.
    Munini M; Popeskou SG; Galetti K; Roesel R; Mongelli F; Christoforidis D
    Int J Colorectal Dis; 2021 Oct; 36(10):2271-2279. PubMed ID: 34467413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.
    Zeng Z; Luo S; Chen J; Cai Y; Zhang X; Kang L
    Surg Endosc; 2020 Sep; 34(9):3956-3962. PubMed ID: 31586244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term outcomes by a transanal approach to total mesorectal excision for rectal cancer.
    Marks JH; Myers EA; Zeger EL; Denittis AS; Gummadi M; Marks GJ
    Surg Endosc; 2017 Dec; 31(12):5248-5257. PubMed ID: 28643051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis.
    Zhang X; Gao Y; Dai X; Zhang H; Shang Z; Cai X; Shen T; Cheng X; Yu K; Li Y
    Surg Endosc; 2019 Mar; 33(3):972-985. PubMed ID: 30374790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transanal versus laparoscopic total mesorectal excision: a comparative study of long-term oncological outcomes.
    Ourô S; Ferreira M; Roquete P; Maio R
    Tech Coloproctol; 2022 Apr; 26(4):279-290. PubMed ID: 35050434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transanal down-to-up dissection of the distal rectum as a viable approach to achieve total mesorectal excision in laparoscopic sphincter-preserving surgery for rectal cancer near the anus: a study of short- and long-term outcomes of 123 consecutive patients from a single Japanese institution.
    Kagami S; Funahashi K; Koda T; Ushigome T; Kaneko T; Suzuki T; Miura Y; Nagashima Y; Yoshida K; Kurihara A
    World J Surg Oncol; 2022 Nov; 20(1):363. PubMed ID: 36376924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of a Single Surgeon-Based Transanal-Total Mesorectal Excision (TATME) for Rectal Cancer.
    Caycedo-Marulanda A; Jiang HY; Kohtakangas EL
    J Gastrointest Cancer; 2018 Dec; 49(4):455-462. PubMed ID: 28702861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international multicentre prospective audit of elective rectal cancer surgery; operative approach versus outcome, including transanal total mesorectal excision (TaTME).
    2017 European Society of Coloproctology (ESCP) collaborating group
    Colorectal Dis; 2018 Sep; 20 Suppl 6():33-46. PubMed ID: 30255642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the short-term outcomes in lower rectal cancer using three different surgical techniques: Transanal total mesorectal excision (TME), laparoscopic TME, and open TME.
    Chen YT; Kiu KT; Yen MH; Chang TC
    Asian J Surg; 2019 Jun; 42(6):674-680. PubMed ID: 30318319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of transanal total mesorectal excision for rectal cancer: comparison of short-term outcomes with laparoscopic and open surgeries.
    Perdawood SK; Thinggaard BS; Bjoern MX
    Surg Endosc; 2018 May; 32(5):2312-2321. PubMed ID: 29098433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of short- and long-term outcomes between laparoscope-assisted transanal total mesorectal excision and laparoscopic total mesorectal excision for the treatment of mid and low rectal cancer: a meta-analysis].
    Zhang X; Gao Y; Dai X; Zhang H; Cheng X; Li Q; Cai X; Shen T; Sun X; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Aug; 21(8):924-935. PubMed ID: 30136274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of transanal total mesorectal excision (TaTME) versus laparoscopic TME for rectal cancer: A case matched study.
    Ye J; Tian Y; Li F; van Oostendorp S; Chai Y; Tuynman J; Tong W
    Eur J Surg Oncol; 2021 May; 47(5):1019-1025. PubMed ID: 33309105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M; Elmore U; Shams N; Hegazy MAF; Roshdy S; Eldamshety O; Metwally IH; Rosati R
    J Laparoendosc Adv Surg Tech A; 2020 Jul; 30(7):769-776. PubMed ID: 32240035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.